Home
Home » companies

Human Genome Sciences

10 top drug launch disasters

10 top drug launch disasters
Fierce Pharma

AstraZeneca In Strong Position With Brilinta

AstraZeneca In Strong Position With Brilinta
Seeking Alpha

GlaxoSmithKline: Don't Pass On This Long-Term Gem

GlaxoSmithKline: Don't Pass On This Long-Term Gem
Seeking Alpha

9 Rallying Healthcare Stocks Seeing Strong Sales Trends

9 Rallying Healthcare Stocks Seeing Strong Sales Trends
Seeking Alpha

GSK completes $3 billion acquisition of Human Genome

GSK completes $3 billion acquisition of Human Genome
Reuters

Loss at HGSI Wider Than Expected

Loss at HGSI Wider Than Expected
Yahoo/Zacks

GlaxoSmithKline's R&D Is Delivering, But The Street's Not Buying

GlaxoSmithKline's R&D Is Delivering, But The Street's Not Buying
Seeking Alpha

A Busy Week For Bio-Pharma Earnings, Drug Approvals

A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com

Dealtalk: Surge in biotech deals to unlock big investor profits

Dealtalk: Surge in biotech deals to unlock big investor profits
Reuters

Human Genome agrees to Glaxo's $3.6B bid

Human Genome agrees to Glaxo's $3.6B bid
Marketwatch